Title: Head of U.S. Marketing for the LSD Porftolio
Company: Chiesi Global Rare Diseases
Location: Boston, Massachusetts, United States
Dinesh R. Vannan, Head of U.S. Marketing for the LSD Porftolio at Chiesi Global Rare Diseases, has been recognized by Marquis Who’s Who Top Healthcare Professionals for dedication, achievements, and leadership in marketing and the sciences.
An esteemed professional in the field of marketing and rare diseases, Mr. Vannan has excelled as the head of U.S. marketing for the LSD portfolio at Chiesi Global Rare Diseases, part of Chiesi USA, Inc. since 2023. In this position, he has led a marketing team dedicated to two critical products: one addressing Fabry disease and another focusing on alpha mannosidosis. His responsibilities encompass overseeing marketing operations for the entire organization, from crafting marketing materials to managing the salesforce and driving data insights. Mr. Vannan’s leadership extends to steering the overall U.S. profit and loss statement, showcasing his comprehensive expertise in the pharmaceutical industry.
Prior to his present role, Mr. Vannan served as the director of marketing for the rare disease portfolio at Chiesi USA, Inc. from 2020 to 2023. During this period, he achieved a significant milestone by launching a groundbreaking product for Fabry disease, marking only the second new product in this competitive space over the past two decades. This achievement, which he cites among the highlights of his career, underscores his commitment to addressing unmet patient needs and navigating challenging markets dominated by major competitors like Sanofi.
Mr. Vannan began his career as a research assistant at Brigham and Women’s Hospital from 2011 to 2013 and Boston Children’s Hospital until 2013. He subsequently transitioned into the field of pharmaceutical marketing as a scientific analyst at McCann Torre Lazur from 2014 to 2016 before working as the associate medical director at greyhealth group (ghg) from 2016 to 2018 and senior strategist at McCann Health in 2018. He further honed his skills as an associate director of strategy and later vice president of strategic planning at McCann Health in 2019 before accepting a post as director of health care professional marketing with Intarcia Therapeutics, Inc. from 2019 to 2020.
Mr. Vannan initially supported his professional ambitions with a Bachelor of Science in biology with a major in neuroscience from Boston College in 2013. This educational background has been instrumental in shaping his understanding of complex medical concepts and enhancing his ability to engage effectively with leaders across various sectors. He attributes much of his success to the collaborative teams and mentors who have supported him throughout his career.
Beyond his professional achievements, Mr. Vannan is actively involved in philanthropic efforts aimed at improving education and infrastructure in Sri Lanka. He is also associated with Tamil Sangam, reflecting his commitment to civic-minded organizations. In recognition of his contributions to the pharmaceutical industry, Mr. Vannan was presented with the PM360 Pharma Trailblazer Award in 2023.
Born in Northern California, Mr. Vannan is renowned among his peers for his exceptional ability to assemble and support effective teams. His reputation for collaboration precedes him, with individuals often seeking his involvement due to his capacity to meaningfully assist and contribute those in need. Looking toward the future, he aims to continue leading in the commercial space industry, focusing on rare diseases and launching new products while expanding his team and exploring opportunities for global commercial leadership within pharmaceutical or biotech organizations.
For more information, please visit:
LinkedIn
PM360
Contact Mr. Vannan:
